Close

NLA Provides Amarin's (AMRN) Vascepa With Yet Another Positive Recommendation - Cantor Fitzgerald

September 16, 2019 10:32 AM EDT Send to a Friend
Cantor Fitzgerald analyst Louise Chen reiterated an Overweight rating and $35.00 price target on Amarin Corporation (NASDAQ: AMRN) after the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login